NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/05/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization147.36 mln
Float5.21 mln
Earnings Date05/04/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.14
Reliable
Relative Strength
93
/ 100
Top performer
Debt / Equity
-29.56
Negative equity
ROE
-610
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Biodesix is a medical diagnostics company based in Louisville, Colorado, focused on helping doctors detect and manage lung cancer through blood-based testing. Its key products help identify whether lung nodules are likely to be cancerous and guide treatment decisions by analyzing tumor mutations and immune system activity. The company also supports pharmaceutical and life sciences firms with services ranging from early biomarker research through to clinical trial testing and regulatory assistance. Founded in 2005, Biodesix operates its own laboratories and has built its business around making lung cancer diagnosis faster and more precise.